News & Updates
Filter by Specialty:
Men with PsA derive more benefit from MTX+ETN therapy than women
Combination therapy with methotrexate (MTX) plus etanercept (ETN) results in more improved outcomes in men than in women with psoriatic arthritis (PsA) for minimal disease activity (MDA) and Psoriatic Arthritis Disease Activity Score (PASDAS), a study has shown.
Men with PsA derive more benefit from MTX+ETN therapy than women
09 Aug 2022
Ivabradine SR improves heart function in patients with HFrEF
Once-daily treatment with sustained-release (SR) ivabradine hemisulfate, alongside optimum standard therapy, results in better heart function in patients with chronic heart failure with reduced ejection fraction (HFrEF), reports a study.
Ivabradine SR improves heart function in patients with HFrEF
08 Aug 2022
BP-lowering drug helps prevent Parkinson’s disease
Treatment with angiotensin receptor blockers (ARBs) appears to reduce the risk of Parkinson’s disease (PD) in patients newly diagnosed with hypertension, reports a recent study.
BP-lowering drug helps prevent Parkinson’s disease
08 Aug 2022
Long-acting injectable HIV drug works for all ages
The long-acting combination of cabotegravir plus rilpivirine, administered as monthly or once-every-2-months jabs, appears to be effective in both older and younger patients living with HIV, with most maintaining virologic suppression through week 96, according to pooled data from the phase III ATLAS, FLAIR, and ATLAS-2M studies.